Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study
暂无分享,去创建一个
J. Wang | W. Fang | Yun-peng Yang | Yuanyuan Zhao | Li Zhang | Z. Hou | Yan Huang | Qun Chen | Yang Zhang | Qianwen Liu | Jinhui Xue | Shaorong Li | Hongyun Zhao | Yuxiang Ma | Jing Wang | Yunpeng Yang